Evidence map›Paper›PMID 25165877›Full record

ArticleCell death & disease2014

Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway.

N Milosch, G Tanriöver, A Kundu, A Rami, J-C François, F Baumkötter, S W Weyer, A Samanta, A Jäschke, F Brod and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Amyloid, APP, and Electrical Activity of the Brain.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Going Too Far Is the Same as Falling ShortFrontiers in cellular neuroscience · 2019
    Review
  16. Article
  17. Article
  18. DistinctThe EMBO journal · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

N MiloschExperimental Neurosurgery, Goethe University Hospital, Frankfurt am Main, Germany.
G TanriöverExperimental Neurosurgery, Goethe University Hospital, Frankfurt am Main, Germany.
A KunduExperimental Neurosurgery, Goethe University Hospital, Frankfurt am Main, Germany.
A RamiInstitute of Cellular and Molecular Anatomy (Anatomie III), Frankfurt University Hospital, Frankfurt am Main, Germany.
J-C FrançoisInserm and Sorbonne Universities, UPMC, Research Center Saint-Antoine, Paris, France.
F BaumkötterDivision of Human Biology and Human Genetics, Technical University of Kaiserslautern, Kaiserslautern, Germany.
S W WeyerDepartment of Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
A SamantaDepartment of Pharmaceutical Chemistry, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
A JäschkeDepartment of Pharmaceutical Chemistry, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
F BrodMolecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.
C J BuchholzMolecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.
S KinsDivision of Human Biology and Human Genetics, Technical University of Kaiserslautern, Kaiserslautern, Germany.
C BehlInstitute for Pathobiochemistry, University Medical Center, Mainz University, Mainz, Germany.
U C MüllerDepartment of Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
D KögelExperimental Neurosurgery, Goethe University Hospital, Frankfurt am Main, Germany.
Heidelberg University · DEUniversity Hospital Frankfurt · DEPaul Ehrlich Institut · DEUniversity of Kaiserslautern · DEGoethe University Frankfurt · DEInserm · FRUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence indicates that loss of physiologic amyloid precursor protein (APP) function leads to reduced neuronal plasticity, diminished synaptic signaling and enhanced susceptibility of neurons to cellular stress during brain aging. Here we investigated the neuroprotective function of the soluble APP ectodomain sAPPα (soluble APPα), which is generated by cleavage of APP by α-secretase along the non-amyloidogenic pathway. Recombinant sAPPα protected primary hippocampal neurons and SH-SY5Y neuroblastoma cells from cell death induced by trophic factor deprivation. We show that this protective effect is abrogated in neurons from APP-knockout animals and APP-depleted SH-SY5Y cells, but not in APP-like protein 1- and 2- (APLP1 and APLP2) depleted cells, indicating that expression of membrane-bound holo-APP is required for sAPPα-dependent neuroprotection. Trophic factor deprivation diminished the activity of the Akt survival pathway. Strikingly, both recombinant sAPPα and the APP-E1 domain were able to stimulate Akt activity in wild-type (wt) fibroblasts, SH-SY5Y cells and neurons, but failed to rescue in APP-deficient neurons or fibroblasts. The ADAM10 (a disintegrin and metalloproteinase domain-containing protein 10) inhibitor GI254023X exacerbated neuron death in organotypic (hippocampal) slice cultures of wt mice subjected to trophic factor and glucose deprivation. This cell death-enhancing effect of GI254023X could be completely rescued by applying exogenous sAPPα. Interestingly, sAPPα-dependent Akt induction was unaffected in neurons of APP-ΔCT15 mice that lack the C-terminal YENPTY motif of the APP intracellular region. In contrast, sAPPα-dependent rescue of Akt activation was completely abolished in APP mutant cells lacking the G-protein interaction motif located in the APP C-terminus and by blocking G-protein-dependent signaling with pertussis toxin. Collectively, our data provide new mechanistic insights into the physiologic role of APP in antagonizing neurotoxic stress: they suggest that cell surface APP mediates sAPPα-induced neuroprotection via G-protein-coupled activation of the Akt pathway.

Indexed as

ADAM10 ProteinADAM ProteinsAmino Acid MotifsAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAnimalsCell LineCell SurvivalDipeptidesHippocampusHumansHydroxamic AcidsIn Vitro TechniquesMembrane ProteinsMiceMice, Inbred C57BL3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2,2-dimethyl-1-methylcarbamoyl-1-propyl)amideADAM10 ProteinADAM10 protein, humanADAM ProteinsAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesDipeptidesHydroxamic AcidsMembrane ProteinsPertussis ToxinPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-aktRecombinant Proteins

Identifiers

PMID25165877
PMCPMC4454324
OpenAlexW2011551155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.